ombitasvir   Click here for help

GtoPdb Ligand ID: 11272

Synonyms: ABT-267 | ABT267 | compound 38 [PMID: 24400777] | Technivie® (ombitasvir + paritaprevir + ritonavir) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU)
Approved drug
ombitasvir is an approved drug (FDA (2015), EMA (2020))
Compound class: Synthetic organic
Comment: Ombitasvir is an orally available, direct-acting inhibitor of the hepatitis C virus (HCV) non-structural protein 5A (NS5A) replication complex [1]. In common with many other NS5A inhibitors it is a dinucleotide derivative.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 15
Hydrogen bond donors 4
Rotatable bonds 22
Topological polar surface area 178.72
Molecular weight 893.51
XLogP 7.7
No. Lipinski's rules broken 3
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)OC)C(C)C
Isomeric SMILES COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc(cc1)[C@@H]1CC[C@H](N1c1ccc(cc1)C(C)(C)C)c1ccc(cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)OC)C(C)C
InChI InChI=1S/C50H67N7O8/c1-30(2)42(53-48(62)64-8)46(60)55-28-10-12-40(55)44(58)51-35-20-14-32(15-21-35)38-26-27-39(57(38)37-24-18-34(19-25-37)50(5,6)7)33-16-22-36(23-17-33)52-45(59)41-13-11-29-56(41)47(61)43(31(3)4)54-49(63)65-9/h14-25,30-31,38-43H,10-13,26-29H2,1-9H3,(H,51,58)(H,52,59)(H,53,62)(H,54,63)/t38-,39-,40-,41-,42-,43-/m0/s1
InChI Key PIDFDZJZLOTZTM-KHVQSSSXSA-N
Classification Click here for help
Compound class Synthetic organic
Approved drug? Yes (FDA (2015), EMA (2020))
Withdrawn drug? Yes
WHO Essential Medicine WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version.
Click to view more information about the WHO Model Lists of Essential Medicines.
IUPAC Name Click here for help
methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
International Nonproprietary Names Click here for help
INN number INN
9740 ombitasvir
Synonyms Click here for help
ABT-267 | ABT267 | compound 38 [PMID: 24400777] | Technivie® (ombitasvir + paritaprevir + ritonavir) | Viekirax® (ombitasvir + paritaprevir + ritonavir; EU)
Database Links Click here for help
CAS Registry No. 1258226-87-7 (source: WHO INN record)
ChEMBL Ligand CHEMBL3127326
DrugBank Ligand DB09296
DrugCentral Ligand 4912
GtoPdb PubChem SID 434321707
PubChem CID 54767916
Search Google for chemical match using the InChIKey PIDFDZJZLOTZTM-KHVQSSSXSA-N
Search Google for chemicals with the same backbone PIDFDZJZLOTZTM
Search PubMed clinical trials ombitasvir
Search PubMed titles ombitasvir
Search PubMed titles/abstracts ombitasvir
UniChem Compound Search for chemical match using the InChIKey PIDFDZJZLOTZTM-KHVQSSSXSA-N
UniChem Connectivity Search for chemical match using the InChIKey PIDFDZJZLOTZTM-KHVQSSSXSA-N